Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Nat Rev Drug Discov. 2022 May 30;21(12):899–914. doi: 10.1038/s41573-022-00472-w

Figure 3.

Figure 3.

Target identification is sometimes perceived as necessary and having a simple binary outcome: the target is identified or it is not (Panel A, legacy thinking). We suggest instead that a continuum of information can be accessed which may address the true end goal of target identification, helping obtain sufficient confidence in safety and translation to support progression into the clinic (Panel B, emerging thinking). TI: Therapeutic index.